Research Projects & Grants

For Profit Organization

• A double-blind, controlled, multicenter phase 2/3 study to assess the safety and efficacy of AVP-923 (dextromethorphan/quinidine) in the treatment of pseudobulbar affect in patients with amyotrophic lateral sclerosis, Role: Investigator, AVANIR Pharmaceuticals, Status: Completed